Skip to content

Drug interactions

Dexlansoprazole + Risedronate

Severity: Minor

Dexlansoprazole and Risedronate: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Delayed-release risedronate formulations contain a pH-sensitive coating, and higher gastric pH can cause earlier release and greater absorption. Separately, long-term PPI use is linked to fracture risk, which is relevant in osteoporosis patients.

What this interaction means in plain words

Dexlansoprazole and Risedronate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dexlansoprazole belongs to Gastrointestinal Tract; Risedronate belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Elevated gastric pH alters release from pH-dependent delayed-release risedronate, increasing absorption.

What to do

Use the immediate-release formulation or review the need for the PPI; no dose change is typically needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexlansoprazole and Risedronate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexlansoprazole with Risedronate?

MediHelp rates the interaction as minor. Dexlansoprazole and Risedronate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Delayed-release risedronate formulations contain a pH-sensitive coating, and higher gastric pH can cause earlier release and greater absorption. Separately, long-term PPI use is linked to fracture risk, which is relevant in osteoporosis patients.

How serious is the interaction between Dexlansoprazole and Risedronate?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the immediate-release formulation or review the need for the PPI; no dose change is typically needed.

What other medicines interact with Dexlansoprazole?

MediHelp also lists interactions of Dexlansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Dexlansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in